GLOBAL SUMMIT ON INTELLECTUAL PROPERTY & ACCESS TO MEDICINES
PATHWAYS TO ACCESS
15 - 17 January 2018
Marrakesh, Morocco
Time / Session / SpeakersDay I
15 January 2018
8:00 - 9:00 / Registration
9:00 - 10:30 / Opening Session
Welcome address
Keynote address
Setting the context / Mayor of Marrakesh
Government of Morocco representative
Community representative
Solange Baptiste, ITPC
Jorge Bermudez, UN High Level Panel on Access to Medicines
10:30 - 11:00 / Tea Break
11:00 - 1 pm / Plenary I
Return to Marrakesh: Two decades of TRIPS and access to medicines
Moderator: Shereen El
Fekki / What we signed in Marrakesh
Carlos Correa, University of Buenos Aires, Argentina (video)
High prices versus low costs of medicines - what is going wrong?
Andrew Hill, University of Liverpool, United Kingdom
Paving the pathway to compulsory licensing in Hep C: The first ever compulsory license
Patent law reform in South Africa
Marumo Nkomo, Department of Trade and Industry, South Africa
TRIPS and access to medicines in Africa: Nothing to see here?
Allan Malleche, KELIN, Kenya
TRIPS flexibilities: the importance of policy coherence
Brook Baker, Healthgap
International institutions and the use of TRIPS flexibilities
German Velasquez, South Centre, Switzerland
Are the TRIPS flexibilities enough? A community perspective
Lorena Di Giano,FGEP, Argentina
13:00 - 14:00 / Lunch
14.00 - 16.00 / Plenary II
The role of civil society in the TRIPS flexibilities implementation
Moderator: Othoman Mellouk / The role of civil society in issuing compulsory licenses (CLs): the case of the Malaysian HepC CL
Fifa Rahman, Malaysia
Civil society and patent oppositions
Tahir Amin, I-MAK, USA
Patent law reform and civil society in South Africa
Lotti Rutter, TAC, South Africa
Civil society and Free Trade Agreements (FTA) in Asia
Shiba Phurailatpam, APN+, Thailand
Civil society and ‘Big Pharma’ litigation
Felipe de Carvalho, ABIA, Brazil
Developing a tool for community monitoring of public health sensibility of intellectual property (IP) laws
Gaelle Krikorian, IRIS-ITPCMENA, France
Community capacity building on intellectual property (IP) and access to medicines: Challenges and successes
Lynette Mabote, ARASA
16:00 - 16:30 / Tea Break
16:30 - 18:30 / Parallel session I
Preventing bad patents: The role of patent examination
Moderator: / Why patent examination matters: A review of pharma patents at OAPI and ARIPO
Sangeeta Shashikant, TWN
Patentability ccriteria: Strict laws, strict interpretation, strict application
German Velasquez, South Centre, Switzerland
Patent office rejections of pharma patents in India: A review Feroz Ali, India
The importance of patent oppositions in assisting patent examination
Tahir Amin, I-MAK, USA
Patent examination: Should the Ministry of Health have a role?
Pedro Villardi, ABIA, Brazil
Patent examination from patent office perspectives:
Mounsif Elafia, OMPIC, Morocco (Introduction of observation system)
Abdel E. Oweida, Egyptian patent office, Egypt (rejection of SOF, DCV)
Ukraine Patent Office?
Civil society perspectives: Opportunities, challenges and lessons learned
Chalermsak Kittitrakul, AIDS Access Foundation, Thailand
16:30 - 18:30 / Parallel Session II
Making compulsory licenses (CLs) routine
Moderator: / Ecuador’s compulsory license regime
Daniel de la Torre, Ministry of Health, Ecuador
Compulsory licences in developed countries
Jamie Love, KEI, USA
Compulsory licenses: developments in Latin America (Chile, Peru and Colombia)
Francisco Rossi, IFARMA, Columbia
Ten years of the Thai CLs: reflecting on the victories and losses of civil society
Chalermsak Kittitrakul, AIDS Access Foundation, Thailand
Indonesia’s compulsory licenses: Challenges in operationalisation
Sindi Putri, Indonesia AIDS Council
Is an effectively automatic CL system possible?
Jorge Bermudez, Fiocruz, Brazil
(10yrs of BR CL)
20.00 / Group Dinner
Day II - 16 January 2018
8.30 - 9:00 / Registration
9.00 – 11.00 / Plenary III
Leaving TRIPS behind:Understanding and resisting TRIPS-plus measures
Moderator: / Trading out our lives
Loon Gangte, ITPC, India
From TRIPS to TRIPS+
Mohamed El Said, UK
EU-Mercusor impact analysis:
Lorena di Giano, FGEP, Argentina
Marcela FogacaViera, Brazil
EU Association Agreement
Oksana Kashyntseva, National Institute on Intellectual Property, and Sergey Kondratyuk, the Network
TPP: The peoples resistance (in Spanish with translation)
Javier LLamosa, AIS, Peru
The role of parliamentarians in FTAs
Omar Balafrej, Parliamentarian, Morocco
Negotiating on behalf developing countries
Daniel Pinto, Ministry of Foreign Affairs, Brazil
11:00 - 11:30 / Tea break
11:30 - 13:00 / Roundtables
Roundtable I
TRIPS-minus: How can LDCs make effective use of the transition periods
Moderator: Allan Maleche, KELIN, Kenya / The importance of the LDC transition periods
Henry Zakumumpa, Makerere University
Chikosa Banda, University of Malawi
Shiba Phurailatpam, APN+
How are LDCs in Africa making use of the transition periods?
Yunus Mohammed, SARPAM
Lynette Mabote, ARASA
Sangeeta Shashikant, TWN
Safiatou Simpré Diaz, Yolse, Burkina Faso
What do CS groups in LDCs need to support the full use of transition periods by their governments: Voices from Asia-Pacific
Thwadar Htun, Myanmar Positive Group
Wangda Dorji, Lhak Sam, Bhutan
Habiba Akhtar, Bangladesh Positive Network
Are LDCs really using the transition periods?
Kajal Bhardwaj, India
Brook Baker, Health Gap
Roundtable II
Local production and technology transfer
Moderator: Aziz Abdur Rehman / Why local production is important: examples and voices of local producers
Dr. Shereen Helmy, Pharco Egypt
Yasmine Lahlou Filali, Pharma5, Morocco
Government policies to support local production: the example of South Africa
Marumo Nkomo, DTi, South Africa
The West African Pharma Local Production Plan
UNAIDS
Government production: the Thai and Brazil examples
Gabriella Costa Chavez, Fiocruz, Brazil (via skype)
Chalermsak Kittitrakul, AIDS Access Foundation, Thailand
Local Production: Possibilities and Realities
UNCTAD
13:00 - 14:00 / Lunch break
14.00 – 15.30 / Roundtables
Roundtable III
Pro-health patent law reform in developing countries:Possibilities and challenges
Moderator: German Velasquez / Two decades after TRIPS, why is patent law reform important? Brook Baker
Government initiatives and challenges in patent law reform
Daniel de la Torre, Ministry of Health, Ecuador
Daniel Pinto, Ministry of Foreign Affairs, Brazil
Omar Balafrej, Parliamentarian, Morocco
Marumo Nkomo, DTi, South Africa
Law reform and recommendations of HLP:
Judith Rius Sanjuan, UNDP
CS experiences in engaging with patent law reform:
Sindi Putri, Indonesia AIDS Council
Anele Yewa and Lotti Rutter TAC, South Africa
ABIA, Brazil
Do Dang Dong, VNP+
Kirghistan (confirmed)
UNDP
Roundtable IV
Challenging unmerited patents
Moderator: Leena Menghaney (MSF) / Civil Society Patent Challenges: Successes and Challenges
Sergey Kondratyuk, The Network, Ukraine
Lorena DiGiano, FGEP, Argentina
MDM? On the EU patent challenges
Patent Oppositions: Perspectives from Patent Offices
Georgina Gerde, National Patent Administration, Argentina
Ukraine Patent Office?
Impact of civil society patent oppositions
Tahir Amin, I-MAK
Feroz Ali, India
15.30 – 16.00 / Tea Break
16.00 – 17.30 / Plenary Panel IV:
Sustaining and supporting civil society work on intellectual property (IP)
Moderator: ShibaPhurailatpam, APN+ / Mandeep Dhaliwal, UNDP (video)
Karin Timmermans / Jan Akko, UNITAID
Jorrit Kabel, AIDSFOND, Netherlands
Julia Greenberg, OSF
CS delgations to UTD and GFATM:
Fifa Rahman, Malaysia
Morgane Ahmar, Morocco
Solange Baptiste, ITPC, Trinidad & Tobago
Anele Yawa, TAC
Day 3
9:30 - 11:00 / Closing Plenary
Patents and access to medicines: A radical agenda?
Moderator: / Stephen Lewis (video)
Jorge Bermudez, Member, UN High Level Panel on Access to Medicines, Brazil
Shiba Phurailatpam, Member UN High Level Panel on Access to Medicines
Michele Childs, DNDI
German Velasquez, South Centre
KM Gopakumar, TWN
Babalwa Malgas, South Africa
Loon Gangte, ITPC India
11 - 11.30 / Tea
11.30 - 12.30 / Report back and closing
12.30 - 13.30 / Lunch
13.30 onwards / Civil society strategy sessions